Jump to content

Hikma приобретает инъекционный бизнес у Boehringer Ingelheim

Recommended Posts

Иорданская фармацевтическая компания Hikma Pharmaceuticals, акции которой торгуются на Лондонской фондовой бирже, объявила о приобретении дженерикового инъекционного бизнеса у немецкой Boehringer Ingelheim, сообщает Reuters.

Читать дальше

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Recently Browsing   0 members

    No registered users viewing this page.

  • Create New...